Skip to main content
Erschienen in: International Journal of Colorectal Disease 1/2012

01.01.2012 | Original Article

Does the outcome of colonic flexure cancers differ from the other colonic sites?

verfasst von: Irshad A. Shaikh, Stuart A. Suttie, Mary Urquhart, Amin I. Amin, Thomas Daniel, Satheesh Yalamarthi

Erschienen in: International Journal of Colorectal Disease | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

Anecdotally, colonic flexure cancers (FC) appear to have a poorer prognosis compared to other colonic cancers (OCC). The aim of this study was to determine the outcome of colonic flexure cancers compared to the cancers of the rest of the colon.

Methods

Patients with a diagnosis of colonic cancer over a 5-year period (2002–2006) were retrieved from a prospective database. Analysis was performed on flexure (hepatic/splenic) cancers versus remaining colon cancers. Overall, 1-, 3- and 5-year survival rates were calculated. All patients were followed up until death or end of study period (December 2008), with median follow-up of 32 months. Statistical analysis was performed using Kaplan–Meier with log rank statistic and Pearson chi-square test.

Results

Of 613 patients (54% males) with colonic cancers with median age 71 years, range (30–100), 67 (10.9%) were FC (35 hepatic/32 splenic) and 546 (89.1%) were arising from OCC. The curative resection rates were FC 73.2% (41 of 56) and OCC 83.4% (359 of 435) (p = 0.05). Post-operative mortality for FC and OCC was 10.7% (6 of 56) and 4.2% (18 of 434), respectively (p = 0.04). FC presented at a more advanced Dukes stage (p = 0.003). Recurrence rates were 9.8% (4 of 41) for FC and 20.9% (75 of 359) for OCC sites (p = 0.088). The overall mean survival was 48.8 and 58.2 m for FC and OCC, respectively (p = 0.158). Of 1-, 3- and 5-year survival, only 1-year survival was significantly different between the two groups (OCC (85%) vs FC (75%), p = 0.018).

Conclusions

Nearly one in ten colonic cancers is located at a flexure. Despite FC presenting at an advanced stage, leading to a lower curative resection rate, no significant survival difference was noted compared to other colonic sites, beyond the first year.
Literatur
1.
Zurück zum Zitat Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P (2007) Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18:581–592PubMedCrossRef Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P (2007) Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18:581–592PubMedCrossRef
2.
Zurück zum Zitat Aldridge MC, Phillips RK, Hittinger R, Fry JS, Fielding LP (1986) Influence of tumour site on presentation, management and subsequent outcome in large bowel cancer. Br J Surg 73:663–670PubMedCrossRef Aldridge MC, Phillips RK, Hittinger R, Fry JS, Fielding LP (1986) Influence of tumour site on presentation, management and subsequent outcome in large bowel cancer. Br J Surg 73:663–670PubMedCrossRef
3.
Zurück zum Zitat Li FY, Lai MD (2009) Colorectal cancer, one entity or three. J Zhejiang Univ Sci B 10:219–229PubMedCrossRef Li FY, Lai MD (2009) Colorectal cancer, one entity or three. J Zhejiang Univ Sci B 10:219–229PubMedCrossRef
4.
Zurück zum Zitat Gervaz P, Bucher P, Neyroud-Caspar I, Soravia C, Morel P (2005) Proximal location of colon cancer is a risk factor for development of metachronous colorectal cancer: a population-based study. Dis Colon Rectum 48:227–232PubMedCrossRef Gervaz P, Bucher P, Neyroud-Caspar I, Soravia C, Morel P (2005) Proximal location of colon cancer is a risk factor for development of metachronous colorectal cancer: a population-based study. Dis Colon Rectum 48:227–232PubMedCrossRef
5.
Zurück zum Zitat Khafagy MM, Stearns MW Jr (1973) Carcinoma of the splenic flexure. Dis Colon Rectum 16:504–507PubMedCrossRef Khafagy MM, Stearns MW Jr (1973) Carcinoma of the splenic flexure. Dis Colon Rectum 16:504–507PubMedCrossRef
6.
Zurück zum Zitat Bufill JA (1990) Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location. Ann Intern Med 113:779–788PubMed Bufill JA (1990) Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location. Ann Intern Med 113:779–788PubMed
7.
Zurück zum Zitat Nakagoe T, Sawa T, Tsuji T, Jibiki M, Nanashima A, Yamaguchi H, Yasutake T, Ayabe H, Ishikawa H (2000) Carcinoma of the splenic flexure: multivariate analysis of predictive factors for clinicopathological characteristics and outcome after surgery. J Gastroenterol 35:528–535PubMedCrossRef Nakagoe T, Sawa T, Tsuji T, Jibiki M, Nanashima A, Yamaguchi H, Yasutake T, Ayabe H, Ishikawa H (2000) Carcinoma of the splenic flexure: multivariate analysis of predictive factors for clinicopathological characteristics and outcome after surgery. J Gastroenterol 35:528–535PubMedCrossRef
8.
Zurück zum Zitat Pihl E, Hughes ES, McDermott FT, Milne BJ, Korner JM, Price AB (1980) Carcinoma of the colon. Cancer specific long-term survival. A series of 615 patients treated by one surgeon. Ann Surg 192:114–117PubMedCrossRef Pihl E, Hughes ES, McDermott FT, Milne BJ, Korner JM, Price AB (1980) Carcinoma of the colon. Cancer specific long-term survival. A series of 615 patients treated by one surgeon. Ann Surg 192:114–117PubMedCrossRef
9.
Zurück zum Zitat Levien DH, Gibbons S, Begos D, Byrne DW (1991) Survival after resection of carcinoma of the splenic flexure. Dis Colon Rectum 34:401–403PubMedCrossRef Levien DH, Gibbons S, Begos D, Byrne DW (1991) Survival after resection of carcinoma of the splenic flexure. Dis Colon Rectum 34:401–403PubMedCrossRef
10.
Zurück zum Zitat Tocchi A, Lepre L, Costa G, Liotta G, Mazzoni G, Agostini N (1996) Carcinoma of the splenic flexure. Nosological and therapeutic contribution. G Chir 17:345–348PubMed Tocchi A, Lepre L, Costa G, Liotta G, Mazzoni G, Agostini N (1996) Carcinoma of the splenic flexure. Nosological and therapeutic contribution. G Chir 17:345–348PubMed
11.
Zurück zum Zitat Kim CW, Shin US, Yu CS, Kim JC (2010) Clinicopathologic characteristics, surgical treatment and outcomes for splenic flexure colon cancer. Cancer Res Treat 42(2):69–76PubMedCrossRef Kim CW, Shin US, Yu CS, Kim JC (2010) Clinicopathologic characteristics, surgical treatment and outcomes for splenic flexure colon cancer. Cancer Res Treat 42(2):69–76PubMedCrossRef
12.
Zurück zum Zitat Nakagoe T, Sawai T, Tsuji T, Jibiki M, Ohbatake M, Nanashima A, Yamaguchi H, Yasutake T, Kurosaki N, Ayabe H, Ishikawa H (2001) Surgical treatment and subsequent outcome of patients with carcinoma of the splenic flexure. Surg Today 31(3):204–209PubMedCrossRef Nakagoe T, Sawai T, Tsuji T, Jibiki M, Ohbatake M, Nanashima A, Yamaguchi H, Yasutake T, Kurosaki N, Ayabe H, Ishikawa H (2001) Surgical treatment and subsequent outcome of patients with carcinoma of the splenic flexure. Surg Today 31(3):204–209PubMedCrossRef
14.
Zurück zum Zitat Phillips RK, Hittinger R, Fry JS, Fielding LP (1985) Malignant large bowel obstruction. Br J Surg 72:296–302PubMedCrossRef Phillips RK, Hittinger R, Fry JS, Fielding LP (1985) Malignant large bowel obstruction. Br J Surg 72:296–302PubMedCrossRef
15.
Zurück zum Zitat Crozier JE, Leitch EF, McKee RF, Anderson JH, Horgan PG, McMillan DC (2009) Relationship between emergency presentation, systemic inflammatory response, and cancer-specific survival in patients undergoing potentially curative surgery for colon cancer. Am J Surg 197:544–549PubMedCrossRef Crozier JE, Leitch EF, McKee RF, Anderson JH, Horgan PG, McMillan DC (2009) Relationship between emergency presentation, systemic inflammatory response, and cancer-specific survival in patients undergoing potentially curative surgery for colon cancer. Am J Surg 197:544–549PubMedCrossRef
Metadaten
Titel
Does the outcome of colonic flexure cancers differ from the other colonic sites?
verfasst von
Irshad A. Shaikh
Stuart A. Suttie
Mary Urquhart
Amin I. Amin
Thomas Daniel
Satheesh Yalamarthi
Publikationsdatum
01.01.2012
Verlag
Springer-Verlag
Erschienen in
International Journal of Colorectal Disease / Ausgabe 1/2012
Print ISSN: 0179-1958
Elektronische ISSN: 1432-1262
DOI
https://doi.org/10.1007/s00384-011-1292-7

Weitere Artikel der Ausgabe 1/2012

International Journal of Colorectal Disease 1/2012 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.